Agents61
US equitySemiconductorsNasdaq

NVIDIA on the committee board

NVIDIA is the AI-infrastructure stress test: exponential demand language meets a supplier with real gross margin and a CUDA lock-in story. Trend seats map the S-curve; quant seats ask whether the print is a cycle peak dressed as a secular trend.

What isolated seats argue

Wood/Laffont adoption curves vs. Dalio/Marks cycle placement. Red team will invert: what if capex pauses, custom ASICs bite, or the customer concentration is one cloud buyer’s budget?

Filing & structure checks

Customer concentration, export controls, inventory at hyperscalers, and how much of “data center” revenue is one generation of GPU. Filings are dense; read the concentration footnote before cheering TAM.

NVIDIA (NVDA)

Observer · 3 seats

Independent briefs, then clerk assembly · 3 isolated prompts + 1 assembly pass · filing facts from SEC EDGAR (cached 7 days) — not investment advice, no buy button

Ask the desk

Preview seating. Paid desks are 16 / 29 / 48 / 61. $49 is Associate (29), not 61. Partners is the same 61 with more compute.

Isolated briefsAssembly1. Era Trend List2. Cycle Position + Thermometer3. Dual-Track Candidate Pool4. Investment Proposal5. Entry Plan6. Exit Discipline

Filing facts · SEC EDGAR

NVIDIA CORP · 10-K FY · FY2026 · ended 2026-01-25 · CIK 0001045810

Public filing · not a live quoteFY2026P/E · P/B · P/S cached model input
Revenue (FY)
$215.9B
Revenue YoY
+65.5%
Net income
$120.1B
Diluted EPS
$4.90
ROE
76.3%
LT debt / equity
0.05
P/E
44.6
P/B
34.03
P/S
24.79
Cached price
$218.36
Mkt cap (est.)
$5.35T

Filings from SEC companyfacts (us-gaap). P/B, P/S from cached price × diluted shares vs filings. Not a live quote. Not a live quote, not advice, not a buy button. Missing numbers stay blank; P/E shows n/m when diluted EPS ≤ 0.

Isolated briefs
3 seats · no peeking

Each master researches NVDA alone

Same file, different rules. Each brief states a view and why. Briefs are written in isolation so one loud narrative cannot drag the room. The clerk reads them only after they exist. Never “you should buy.” There is no buy button.

Warren Buffettconstructive

Constructive — the work is worth continuing, not an order. Owner test on NVDA: P/E 44.6, P/B 34.03, ROE 76.3%, net income $120.1B.

Question: “Research NVDA as a US-listed name.”. Owner earnings lens on NVDA. Plain Midwest English, folksy metaphors, long-horizon. Hard rule: Circle of competence: if the business cannot be explained simply, pass. Numbers on file: P/E 44.6; P/B 34.03; ROE 76.3%; net income $120.1B; revenue YoY 65.5%. On file: 10-K FY FY2026; revenue $215.9B; revenue YoY 65.5%; net income $120.1B; ROE 76.3%; LT debt/equity 0.05; P/E 44.6; P/B 34.0; P/S 24.8; price $218.36 cached. A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk. Underwrite frame: Worth further homework.

Peter Lynchconstructive

Constructive — the work is worth continuing, not an order. Classify NVDA before cheering growth. revenue YoY 65.5%. P/E 44.6.

Question: “Research NVDA as a US-listed name.”. Classify before multiple. Six-category company classification system.. revenue YoY 65.5%. P/E 44.6. revenue $215.9B. On file: 10-K FY FY2026; revenue $215.9B; revenue YoY 65.5%; net income $120.1B; ROE 76.3%; LT debt/equity 0.05; P/E 44.6; P/B 34.0; P/S 24.8; price $218.36 cached. Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay. Underwrite frame: Worth further homework.

Charlie Mungerskeptical

Skeptical — the burden of proof is on the bull case. Invert NVDA first. What has to be false for the bull to die?

Question: “Research NVDA as a US-listed name.”. Invert NVDA. Invert: how would this thesis get killed? List the kill-shots before the romance. On file: 10-K FY FY2026; revenue $215.9B; revenue YoY 65.5%; net income $120.1B; ROE 76.3%; LT debt/equity 0.05; P/E 44.6; P/B 34.0; P/S 24.8; price $218.36 cached. Name what must be true for the bull: earnings quality, leverage (0.05), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job. Underwrite frame: Pass for now.

Committee tables and charts

Counted from isolated briefs. Ratios are filings or cached model input — not a live quote, not a rating, not a buy button.

Stance mix

3
  • constructive2
  • cautious0
  • skeptical1
  • inconclusive0

Cycle scenario fan (%)

0255075100BoomRecoveryStagflationRecession

Valuation and filings (P/E, P/B, …)

MetricValueNote
P/E44.6P/B, P/S from cached price × diluted shares vs filings. Not a live quote.
P/B34.03P/B, P/S from cached price × diluted shares vs filings. Not a live quote.
P/S24.79
ROE76.3%
LT debt / equity0.05
Revenue (FY)$215.9B
Revenue YoY+65.5%
Net income$120.1B
Diluted EPS$4.90
Clerk assembly

Then the briefs are stacked — not averaged

constructive
2
cautious
0
skeptical
1
inconclusive
0

Where they agree

  • The clerk stacked isolated notes on: “Research NVDA as a US-listed name.”. Masters did not see each other’s drafts.
  • Quality seats treat “would I own the whole company?” as the filter, not next-quarter beat.
  • This preview triangle is quality, growth classification, and inversion. It is a sample, not the full committee.

Where they split

  • Value/quality seats ask whether it is a business worth owning; growth seats ask whether the story is still underappreciated. Those are different tests.
  • Debate seats write kill-shots before any clerk summary. They are not asked to “meet in the middle.”
  • Constructive and skeptical briefs both survived isolation — the clerk does not erase the split.

Cycle, timing, exit, and quant seats are dark on this plan. A three-seat sample cannot locate the cycle or size a position.

Assembly is a second isolated pass over the briefs. Masters did not read each other. Research simulation — not advice, not a buy button.

Analyst unlocks 16 independent seats (16 isolated prompts + 1 assembly pass).

See Analyst

Split after isolation

Counted from independent briefs only — not a vote, not a recommendation.

67%
33%
2 constructive 0 cautious / inconclusive 1 skeptical
Step 1 · Where does capital flow over the next decade?

Era Trend List

Trend research (Wood, Laffont, and the rest of the era desk) is locked on Observer.

Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.

Compare plans
Step 2 · Where are we in the cycle?

Cycle Position Report

Cycle desk (Dalio, Marks, Templeton) is locked on Observer.

Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.

Compare plans
Step 3 · What to buy — why this ticker is in the pool, or not

Why this name (dual track)

Value / Quality track

Warren Buffett

NVDA: screened alone against Moat & Management Final Review.

Growth / Opportunity track

Peter Lynch

NVDA: screened alone against Ten-Bagger Hunter.

Step 4 · Bull case vs. red-team interrogation — after isolation

Investment Proposal

Debate starts only after independent briefs exist. Red team still does not see a shared draft.

Charlie MungerDebate chair · inversion: the best way to kill this thesis

Warren BuffettFinal review · 10-year hold test

Full transcript, risk list, and sizing stay on higher seats.

Unlock more seats
Step 5 · When to buy, and how much

Entry Plan

Timing desk (O’Neil and the tape seats) is locked on Observer.

Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.

Compare plans
Step 6 · When to sell

Exit Discipline

Exit desk (Livermore, Darvas, Bogle accountability) is locked on Observer.

Unlocks on Committee or Partners (61). Empty seats stay empty — we do not ghost-fill them.

Compare plans

Quant Risk Control

Quant (Thorp Kelly sizing, then the full seven on Committee) is locked on Observer.

Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.

Compare plans

Agents61 is a research simulation and educational tool. Isolated views, splits, and assembly notes only. Not personalized advice. AI-generated.